195 related articles for article (PubMed ID: 25355661)
21. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations.
Cho WH; Song WS; Jeon DG; Kong CB; Kim MS; Lee JA; Yoo JY; Kim JD; Lee SY
Ann Surg Oncol; 2010 Mar; 17(3):702-8. PubMed ID: 19921336
[TBL] [Abstract][Full Text] [Related]
22. P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy.
Borys D; Canter RJ; Hoch B; Martinez SR; Tamurian RM; Murphy B; Bishop JW; Horvai A
Hum Pathol; 2012 Nov; 43(11):1948-54. PubMed ID: 22578565
[TBL] [Abstract][Full Text] [Related]
23. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
24. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.
Zuo D; Zheng L; Sun W; Hua Y; Cai Z
World J Surg Oncol; 2013 Jun; 11():148. PubMed ID: 23799947
[TBL] [Abstract][Full Text] [Related]
25. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
[TBL] [Abstract][Full Text] [Related]
26. Marginal excision for osteosarcoma with caffeine assisted chemotherapy.
Tsuchiya H; Tomita K; Mori Y; Asada N; Yamamoto N
Clin Orthop Relat Res; 1999 Jan; (358):27-35. PubMed ID: 9973973
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis in pediatric osteosarcoma: impact of modern therapies.
Hendershot E; Pappo A; Malkin D; Sung L
J Pediatr Oncol Nurs; 2006; 23(4):176-81. PubMed ID: 16766682
[TBL] [Abstract][Full Text] [Related]
28. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract][Full Text] [Related]
29. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
[TBL] [Abstract][Full Text] [Related]
30. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
[TBL] [Abstract][Full Text] [Related]
31. Pelvis and extremity osteosarcoma with similar tumor volume have an equivalent survival.
Song WS; Cho WH; Jeon DG; Kong CB; Kim MS; Lee JA; Eid AS; Kim JD; Lee SY
J Surg Oncol; 2010 Jun; 101(7):611-7. PubMed ID: 20461769
[TBL] [Abstract][Full Text] [Related]
32. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
33. Marginal resection for osteosarcoma with effective preoperative chemotherapy.
Yu XC; Xu M; Song RX; Xu SF
Orthop Surg; 2009 Aug; 1(3):196-202. PubMed ID: 22009842
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
35. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
[TBL] [Abstract][Full Text] [Related]
36. Osteosarcoma around the knee treated with neoadjuvant chemotherapy and a custom-designed prosthesis.
Bi W; Wang W; Han G; Jia J; Xu M
Orthopedics; 2013 Apr; 36(4):e444-50. PubMed ID: 23590783
[TBL] [Abstract][Full Text] [Related]
37. Prognostic effect of pathologic fracture in localized osteosarcoma: a cohort/case controlled study at a single institute.
Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Cho SH; Lee JA; Yoo JY; Jung ST; Jeon DG
J Surg Oncol; 2009 Sep; 100(3):233-9. PubMed ID: 19294672
[TBL] [Abstract][Full Text] [Related]
38. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute.
Staals EL; Bacchini P; Bertoni F
Cancer; 2008 Apr; 112(7):1592-9. PubMed ID: 18300258
[TBL] [Abstract][Full Text] [Related]
39. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.
Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X
Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071
[TBL] [Abstract][Full Text] [Related]
40. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.
Ogura K; Fujiwara T; Yasunaga H; Matsui H; Jeon DG; Cho WH; Hiraga H; Ishii T; Yonemoto T; Kamoda H; Ozaki T; Kozawa E; Nishida Y; Morioka H; Hiruma T; Kakunaga S; Ueda T; Tsuda Y; Kawano H; Kawai A
Cancer; 2015 Nov; 121(21):3844-52. PubMed ID: 26194185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
